Observational studyPloS one2019

Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study.

Yabing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.